Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873.

Krause, Andreas; Kloft, Charlotte; Huisinga, Wilhelm; Karlsson, Mats; Pinheiro, José; Bies, Robert; Rogers, James; Mentré, France; Musser, Bret J

Krause, Andreas; Kloft, Charlotte; Huisinga, Wilhelm; Karlsson, Mats; Pinheiro, José; Bies, Robert; Rogers, James; Mentré, France; Musser, Bret J.

Affiliation

Krause A; Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Germany.
Huisinga W; Computational Physiology, Institute of Mathematics, University of Potsdam, Germany.
Karlsson M; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Pinheiro J; Quantitative Sciences, Janssen Pharmaceutical Companies of Johnson and Johnson, Titusville, New Jersey.
Bies R; Department of Pharmaceutical Sciences, School of Pharmacy, State University of New York at Buffalo, New York.
Rogers J; Computational and Data Enabled Science and Engineering Program, University at Buffalo, New York.
Mentré F; Statistical Modeling and Data Sciences, Metrum Research Group, Tariffvile, Connecticut.
Musser BJ; IAME, UMR1137, Inserm and Université de Paris Diderot, Paris, France.

Pharm Stat ; 18(3): 278-281, 2019 05.

Article in En | MEDLINE | ID: mdl-30932340

Subject(s)

Curriculum; Drug Development

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Curriculum / Drug Development Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2019 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google